Patent: 4,999,291
✉ Email this page to a colleague
Summary for Patent: 4,999,291
Title: | Production of human pluripotent granulocyte colony-stimulating factor |
Abstract: | Disclosed are novel polypeptides possessing part or all of the primary structural conformation and one or more of the biological properties of a mammalian (e.g., human) pluripotent granulocyte colony-stimulating factor (\"hpG-CSF\") which are characterized in preferred forms by being the product of procaryotic or eucaryotic host expression of an exogenous DNA sequence. Sequences coding for part or all of the sequence of amino acid residues of hpG-CSF or for analogs thereof may be incorporated into autonomously replicating plasmid or viral vectors employed to transform or transfect suitable procaryotic or eucaryotic host cells such as bacteria, yeast or vertebrate cells in culture. Products of expression of the DNA sequences display, e.g., the physical and immunological properties and in vitro biological activities of isolates of hpG-CSF derived from natural sources. Disclosed also are chemically synthesized polypeptides sharing the biochemical and immunological properties of hpG-CSF. |
Inventor(s): | Souza; Lawrence M. (Thousand Oaks, CA) |
Assignee: | Amgen Inc. (Thousand Oaks, CA) |
Application Number: | 07/319,919 |
Patent Claims: | see list of patent claims |
Details for Patent 4,999,291
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Amgen, Inc. | NEUPOGEN | filgrastim | Injection | 103353 | 02/20/1991 | ⤷ Try a Trial | 2005-08-23 |
Amgen, Inc. | NEUPOGEN | filgrastim | Injection | 103353 | 06/28/2000 | ⤷ Try a Trial | 2005-08-23 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 4,999,291
Country | Patent Number | Estimated Expiration |
---|---|---|
South Africa | 866412 | ⤷ Try a Trial |
World Intellectual Property Organization (WIPO) | 8701132 | ⤷ Try a Trial |
United States of America | 6716606 | ⤷ Try a Trial |
United States of America | 6379661 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |